Showing results (1-10 of 131) with videos related to
Sort By:
Pageof 14
BMC Systems Biology|April 30, 2010
Dynamics and control of the central carbon metabolism in hepatoma cellsKlaus Maier, Ute Hofmann, Matthias Reuss, et al.Biotechnology and Bioengineering|December 21, 2007
Identification of metabolic fluxes in hepatic cells from transient 13C-labeling experiments: Part II. Flux estimationKlaus Maier, Ute Hofmann, Matthias Reuss, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 13, 2005
Sensitive quantification of omeprazole and its metabolites in human plasma by liquid chromatography-mass spectrometryUte Hofmann, Matthias Schwab, Gerd Treiber, et al.Toxicology and Applied Pharmacology|December 4, 2012
High-dose supplementation with natural α-tocopherol does neither alter the pharmacodynamics of atorvastatin nor its phase I metabolism in guinea pigsMaren C Podszun, Nadine Grebenstein, Ute Hofmann, et al.Scientific Reports|January 14, 2021
Differential effects on human cytochromes P450 by CRISPR/Cas9-induced genetic knockout of cytochrome P450 reductase and cytochrome b5 in HepaRG cellsTamara Heintze, Kathrin Klein, Ute Hofmann, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|February 5, 2002
Determination of fexofenadine in human plasma and urine by liquid chromatography-mass spectrometryUte Hofmann, Monika Seiler, Siegfried Drescher, et al.BMC Cancer|October 17, 2014
Chemically induced mouse liver tumors are resistant to treatment with atorvastatinAlbert Braeuning, Philip Bucher, Ute Hofmann, et al.Biochemical and Biophysical Research Communications|November 22, 2005
Reconstitution of beta-carotene hydroxylase activity of thermostable CYP175A1 monooxygenaseKyoko Momoi, Ute Hofmann, Rolf D Schmid, et al.Annual Review of Pharmacology and Toxicology|August 16, 2023
Circulating Biomarkers Instead of Genotyping to Establish Metabolizer PhenotypesRoman Tremmel, Ute Hofmann, Mathias Haag, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|May 19, 2005
Characterisation of (R/S)-propafenone and its metabolites as substrates and inhibitors of P-glycoproteinIouri Bachmakov, Sabine Rekersbrink, Ute Hofmann, et al.Pageof 14